THB Asset Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-632,499
Closed -$9.47M 178
2016
Q2
$9.47M Sell
632,499
-9,491
-1% -$122K 1.23% 27
2016
Q1
$7.81M Buy
641,990
+26,444
+4% +$371K 0.89% 46
2015
Q4
$9.79M Buy
615,546
+39,896
+7% +$628K 1.05% 30
2015
Q3
$8.82M Buy
575,650
+465,790
+424% +$10.1M 0.87% 36
2015
Q2
$2.67M Sell
109,860
-32,400
-23% -$776K 0.2% 159
2015
Q1
$3.31M Buy
+142,260
New +$3.77M 0.23% 160

THB Asset Management's SGNT Position: Q3 2016 in Review

THB Asset Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 632,499 shares — an estimated $9.47M sold.

THB Asset Management first reported a position in SGNT in Q1 2015 and held it in 6 quarters. The position peaked at $9.79M in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • THB Asset Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • THB Asset Management sold 632,499 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $9.47M.
  • THB Asset Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 6 quarters.
  • THB Asset Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $9.79M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on THB Asset Management's 13F filing for Q3 2016, filed 24 Oct 2016.